Rebif Clinical Trials Rebif RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®: A Retrospective Study
Condition:   Relapsing-remitting Multiple SclerosisInterventions:   Drug: Rebif;   Drug: TecfideraSponsors:   IMS HEALTH GmbH & Co. OHG;   EMD SeronoRecruiting - verified June 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 3, 2016 Category: Research Source Type: clinical trials